Category: Congress Info

Meet the Industries Attending Targeting Phage Therapy 2024

Posted on by Targeting Phage Therapy
Targeting Phage Therapy 2024 gathered 15+ key players in the phage therapy industry to showcase. Participants engaged in meaningful discussions on the latest research, regulatory landscapes, and successful case studies in phage therapy.  Attendees had the opportunity to learn about advancements in phage selection, manufacturing, and production, which are crucial for the development and implementation…

Dr. Schooley’s call to action: Elevating phage therapy trials through strategic translational research

Posted on by Targeting Phage Therapy
The 7th World Conference on Targeting Phage Therapy was organized on June 20-21, 2024 at Corinthia Palace Malta. Robert T. Schooley, M.D., Professor of Medicine at the University of California, San Diego, and Co-Director of the Center for Innovative Phage Applications and Therapeutics and member of the Executive Committee for the University of California Disaster…

Phage-Microbiome Consortium: Interplay and Modulation in Human Health and Disease

Posted on by Targeting Phage Therapy
In collaboration with the International Society of Microbiota (ISM), we are pleased to announce the launch of The Phage-Microbiome Consortium. Aim of the Consortium The aim of this project is to set up a consortium of experts in the field of bacteriophages and the human microbiome, to collectively explore the potential of phages in shaping…

The Concluding Remarks of Targeting Phage Therapy 2023 & Future Perspectives

Posted on by Targeting Phage Therapy
The 6th World Congress on Targeting Phage Therapy 2023 that was held on June 1-2 in Paris, and gathered more than 150 attendees from 30+ different countries. Targeting Phage Therapy 2023 included more than 71 presentations between major talks, short orals, and posters. The Chairman of the scientific committee Dr. Marvin Edeas Université de Paris,…

Phage Therapy 2023 Best Short Oral: Bacteriophage-Antibiotic Combination to Allow Liver Transplantation

Posted on by Targeting Phage Therapy
The Targeting Phage Therapy 2023 Best Short Oral Presentation award was discerned to: Bacteriophage-Antibiotic Combination Therapy Against Extensively Drug-Resistant Pseudomonas Aeruginosa Infection to Allow Liver Transplantation in a Toddler Brieuc Van Nieuwenhuyse, UC Louvain, Belgium Dr. Van Nieuwenhuyse explained to Targeting Phage Therapy: “My research focuses on bidirectional translational research, trying to analyze specific mechanisms…

Targeting Phage Therapy 2023 Best Poster: Thermostable Bactericidal Endolysin Discovery

Posted on by Targeting Phage Therapy
The Targeting Phage Therapy 2023 Best Poster Presentation award was discerned to: New Ways to Fight Bacterial Pathogens: Metagenomics Analysis for the Discovery of a Thermostable Endolysin With High Bactericidal Activity Panagiota Pantiora, Agricultural University of Athens, Greece Ms. Pantiora is currently a PhD student in Enzyme Biotechnology, at the Laboratory of Enzyme Technology of AUA,…

Phiogen CEO was awarded the Phage Therapy 2023 Best Innovation for their technology platform

Posted on by Targeting Phage Therapy
The Targeting Phage Therapy 2023 Best Scientific Contribution award was discerned to: Amanda (Curtis) Burkardt, CEO of PHIOGEN, USA Ms. Burkardt was awarded for creating patient ready products in a remedy ready world. Spun-off from of one of the US’s only phage therapy cores, TAILOR Labs at Baylor College of Medicine, an ambitious new biotech…

Martha Clokie Editor in Chief of PHAGE Journal was awarded the Phage Therapy 2023 Best Scientific Contribution

Posted on by Targeting Phage Therapy
The Targeting Phage Therapy 2023 Best Scientific Contribution award was discerned to: Martha Clokie, Professor at University of Leicester and Editor in Chief of the PHAGE Journal Prof. Clokie was awarded for her talk on phage therapy challenges and opportunities. In her talk, she elaborated on her team’s work in an agricultural setting that has…

PHAGE Therapy, Applications, and Research Journal is a contributing partner

Posted on by Targeting Phage Therapy
PHAGE Therapy, Applications, and Research Journal is a contributing partner of Targeting Phage Therapy 2023 Conference.  Editor in Chief Prof. Martha Clokie from the University of Leicester will be presenting an introductory talk on  the “Challenges and Opportunities for Bacteriophage Therapy”. All the conference proceedings will be published in the journal. So make sure to…